APRE·03836J201·US·equity·Healthcare - Biotechnology-13D/G
APRE (APREA THERAPEUTICS INC) is held by 11 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($90,890), BNP PARIBAS FINANCIAL MARKETS ($30,376), RENAISSANCE TECHNOLOGIES LLC ($19,149). Net institutional sentiment: Mixed.
See how APRE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer